UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration

PloS one, 2014-02, Vol.9 (2), p.e89292-e89292

2014

Volltextzugriff (PDF)

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Pigment cell and melanoma research, 2018-07, Vol.31 (4), p.534-540

2018

Volltextzugriff (PDF)

Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration

PloS one, 2012-07, Vol.7 (7), p.e41845

2012

Volltextzugriff (PDF)

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

Clinical cancer research, 2008-12, Vol.14 (24), p.8302-8307

2008

Volltextzugriff (PDF)

GLI2-Mediated Melanoma Invasion and Metastasis

JNCI : Journal of the National Cancer Institute, 2010-08, Vol.102 (15), p.1148-1159

2010

Volltextzugriff (PDF)

Functional effects of GRM1 suppression in human melanoma cells

Molecular cancer research, 2012-11, Vol.10 (11), p.1440-1450

2012

Volltextzugriff (PDF)

Activation of the Glutamate Receptor GRM1 Enhances Angiogenic Signaling to Drive Melanoma Progression

Cancer research (Chicago, Ill.), 2014-05, Vol.74 (9), p.2499-2509

2014

Volltextzugriff (PDF)

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (5), p.2298-2305

2007

Volltextzugriff (PDF)

Sun protection and exposure behaviors among Hispanic adults in the United States: differences according to acculturation and among Hispanic subgroups

BMC public health, 2012-11, Vol.12 (1), p.985-985, Article 985

2012

Volltextzugriff (PDF)

Glutamatergic Pathway Targeting in Melanoma: Single-Agent and Combinatorial Therapies

Clinical cancer research, 2011-11, Vol.17 (22), p.7080-7092

2011

Volltextzugriff (PDF)

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer

PloS one, 2014-01, Vol.9 (1), p.e81126

2014

Volltextzugriff (PDF)

Exchange Protein Directly Activated by Cyclic AMP Increases Melanoma Cell Migration by a Ca2+-Dependent Mechanism

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (13), p.5607-5617

2010

Volltextzugriff (PDF)

ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways

Proceedings of the National Academy of Sciences - PNAS, 2008-10, Vol.105 (43), p.16713-16718

2008

Volltextzugriff (PDF)

A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma

Clinical cancer research, 2009-06, Vol.15 (11), p.3896-3902

2009

Volltextzugriff (PDF)

Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells

Pigment cell and melanoma research, 2015-01, Vol.28 (1), p.105-109

2015

Volltextzugriff (PDF)

Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling

Pigment cell and melanoma research, 2014-07, Vol.27 (4), p.611-620

2014

Volltextzugriff (PDF)

The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells

Journal of investigative dermatology, 2010-09, Vol.130 (9), p.2240-2249

2010

Volltextzugriff (PDF)

Skin cancer surveillance behaviors among US Hispanic adults

Journal of the American Academy of Dermatology, 2013-04, Vol.68 (4), p.576-584

2013

Volltextzugriff (PDF)

Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma

PloS one, 2012-10, Vol.7 (10), p.e47312

2012

Volltextzugriff (PDF)

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma

Oncotarget, 2016-05, Vol.7 (20), p.29689-29707

2016

Volltextzugriff (PDF)

Epac1 promotes melanoma metastasis via modification of heparan sulfate

Pigment cell and melanoma research, 2011-08, Vol.24 (4), p.680-687

2011

Volltextzugriff (PDF)

Prospective Multi-Institutional Study of Reverse Transcriptase Polymerase Chain Reaction for Molecular Staging of Melanoma

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2849-2857

2006

Volltextzugriff (PDF)

Gβγ subunits inhibit Epac-induced melanoma cell migration

BMC cancer, 2011-06, Vol.11 (1), p.256-256, Article 256

2011

Volltextzugriff (PDF)

Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction

Cancer Immunology, Immunotherapy, 2011-05, Vol.60 (5), p.685-692

2011

Volltextzugriff (PDF)

Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression

Translational oncology, 2015-02, Vol.8 (1), p.1-9

2015

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(114)
Berichte
(1)

Sprache

Englisch
(115)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Humans
(62)
Life Sciences & Biomedicine
(59)
Melanoma - Pathology
(42)
Oncology
(40)
Melanoma
(38)
Dermatology
(31)
Female
(28)
Male
(27)
Melanoma - Metabolism
(23)
Skin Neoplasms - Pathology
(23)
Biological And Medical Sciences
(22)
Cell Line, Tumor
(22)
Medical Sciences
(22)
Middle Aged
(20)
Animals
(19)
Adult
(18)
Mice
(18)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(17)
Aged
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

GLI2-Mediated Melanoma Invasion and Metastasis

Functional effects of GRM1 suppression in human melanoma cells

Activation of the Glutamate Receptor GRM1 Enhances Angiogenic Signaling to Drive Melanoma Progression

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma

Sun protection and exposure behaviors among Hispanic adults in the United States: differences according to acculturation and among Hispanic subgroups

Glutamatergic Pathway Targeting in Melanoma: Single-Agent and Combinatorial Therapies

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer

Exchange Protein Directly Activated by Cyclic AMP Increases Melanoma Cell Migration by a Ca2+-Dependent Mechanism

ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways

A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma

Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells

Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling

The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells

Skin cancer surveillance behaviors among US Hispanic adults

Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma

Epac1 promotes melanoma metastasis via modification of heparan sulfate

Prospective Multi-Institutional Study of Reverse Transcriptase Polymerase Chain Reaction for Molecular Staging of Melanoma

Gβγ subunits inhibit Epac-induced melanoma cell migration

Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction

Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression

Suchergebnisse filtern